What is Alstem?
ALSTEM is a specialized biotechnology services provider, recognized for its comprehensive suite of products and services. The company excels in areas such as induced pluripotent stem cell (iPSC) generation, gene editing, virus packaging, and custom cell line development. Leveraging proprietary tools like HiBiT, HaloTag, NanoLuc, and NanoBiT, ALSTEM empowers researchers with precise protein analysis capabilities essential for cutting-edge research applications. Their commitment to delivering high-quality, rapid solutions positions them as a key partner for scientific institutions aiming to accelerate discovery and development in the life sciences.
How much funding has Alstem raised?
Alstem has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Alstem
PPP
Public-Private Partnership
What's next for Alstem?
With its recent major strategic investment and substantial total funding, Alstem is poised for significant growth and further technological advancement. The company's focus on providing essential biotechnology services and innovative research tools suggests a trajectory aimed at expanding its market reach and deepening its impact within the scientific community. Future developments are likely to involve enhancing its product portfolio and potentially forging new strategic partnerships to capitalize on emerging opportunities in advanced biological research and therapeutic development.
See full Alstem company page
